Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5220625
Max Phase: Preclinical
Molecular Formula: C26H30ClF2N3O
Molecular Weight: 474.00
Associated Items:
ID: ALA5220625
Max Phase: Preclinical
Molecular Formula: C26H30ClF2N3O
Molecular Weight: 474.00
Associated Items:
Canonical SMILES: O=C(c1ccc(F)c(Cl)c1)N1CCC(CNCCCCCc2c[nH]c3ccc(F)cc23)CC1
Standard InChI: InChI=1S/C26H30ClF2N3O/c27-23-14-19(5-7-24(23)29)26(33)32-12-9-18(10-13-32)16-30-11-3-1-2-4-20-17-31-25-8-6-21(28)15-22(20)25/h5-8,14-15,17-18,30-31H,1-4,9-13,16H2
Standard InChI Key: RDKXZEOXLQJAKW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 474.00 | Molecular Weight (Monoisotopic): 473.2045 | AlogP: 5.95 | #Rotatable Bonds: 9 |
Polar Surface Area: 48.13 | Molecular Species: BASE | HBA: 2 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.61 | CX LogP: 5.71 | CX LogD: 2.78 |
Aromatic Rings: 3 | Heavy Atoms: 33 | QED Weighted: 0.38 | Np Likeness Score: -1.26 |
1. Yuan RX, Jiang KY, Wu JW, Zhang ZX, Li MS, Li JQ, Ni F.. (2022) Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT1A., 76 [PMID:36202190] [10.1016/j.bmcl.2022.129006] |
Source(1):